nach oben

Digestive Diseases and Sciences

Erschienen in:

30.07.2021 | Original Article

Poor Sleep in Inflammatory Bowel Disease Is Reflective of Distinct Sleep Disorders

verfasst von: Jessica K. Salwen-Deremer, Michael T. Smith, Hannah G. Haskell, Colleen Schreyer, Corey A. Siegel

Erschienen in: Digestive Diseases and Sciences | Ausgabe 7/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

Poor sleep is common in inflammatory bowel disease (IBD), predicting increased risk of flares, surgery, and/or hospitalization and reducing quality of life.

Aims

To profile specific sleep disorder symptoms in IBD, informing intervention efforts.

Methods

312 adults with Crohn’s disease or ulcerative colitis were recruited from an academic medical center in New Hampshire, USA. Participants completed online surveys about sleep including well-validated measures of sleep quality, insomnia, restless leg syndrome, sleep apnea, and circadian rhythms. Participants also answered questions about IBD-related problems that could interfere with sleep.

Results

69.4% of participants reported experiencing poor sleep and 50% reported clinically significant insomnia. Participants with active IBD symptoms were more likely to have poor sleep and insomnia. Of those with poor sleep, 67.8% met the clinical threshold for insomnia disorder and 31.3% met criteria for two or more sleep disorders. IBD-related sleep disruptions (e.g., nighttime awakenings due to bowel movements) were not significantly related to poor sleep quality, but significantly related to insomnia severity for participants with active Crohn’s disease.

Conclusions

While poor sleep in IBD is reflective of a number of different sleep problems, it is most frequently related to insomnia. IBD symptom severity contributes to insomnia, but insomnia is also distinct from IBD-related sleep disruptions. Future research on the treatment of insomnia disorder in particular in individuals with IBD is warranted.

Nur mit Berechtigung zugänglich

Ananthakrishnan AN, Long MD, Martin CF, Sandler RS, Kappelman MD. Sleep disturbance and risk of active disease in patients with Crohn’s disease and ulcerative colitis. Clin Gastroenterol Hepatol. 2013;11:965–971.PubMedPubMedCentral

Ali T, Madhoun MF, Orr WC, Rubin DT. Assessment of the relationship between quality of sleep and disease activity in inflammatory bowel disease patients. Inflam Bowel Dis. 2013;19:2440–2443.

Iskandar HN, Linan EE, Patel A, Moore R, Lasanajak Y, Gyawali CP et al. Self-reported sleep disturbance in Crohn’s disease is not confirmed by objective sleep measures. Sci Rep. 2020;10:1–9.

Sofia MA, Lipowska AM, Zmeter N, Perez E, Kavitt R, Rubin DT. Poor sleep quality in Crohn’s disease is associated with disease activity and risk for hospitalization or surgery. Inflam Bowel Dis. 2020;26:1251–1259.

Graff LA, Vincent N, Walker JR, Clara I, Carr R, Ediger J et al. A population-based study of fatigue and sleep difficulties in inflammatory bowel disease. Inflam Bowel Dis. 2010;17:1882–1889.

Keefer L, Stepanski EJ, Ranjbaran Z, Benson LM, Keshavarzian A. An initial report of sleep disturbance in inactive inflammatory bowel disease. J Clin Sleep Med. 2006;2:409–416.PubMed

Uemura R, Fujiwara Y, Iwakura N, Shiba M, Watanabe K, Kamata N et al. Sleep disturbances in Japanese patients with inflammatory bowel disease and their impact on disease flare. SpringerPlus. 2016;5:1792.PubMedPubMedCentral

Gingold-Belfer R, Peled N, Levy S, Katz N, Niv Y, Fass R et al. Impaired sleep quality in Crohn’s disease depends on disease activity. Dig Dis Sci. 2014;59:146–151. https://doi.org/10.1007/s10620-013-2890-8.CrossRefPubMed

Kappelman MD, Long MD, Martin C, DeWalt DA, Kinneer PM, Chen W et al. Evaluation of the patient-reported outcomes measurement information system in a large cohort of patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2014;12:1315–1323.PubMed

10.

Ranjbaran Z, Keefer L, Farhadi A, Stepanski E, Sedghi S, Keshavarzian A. Impact of sleep disturbances in inflammatory bowel disease. J Gastroenterol Hepatol. 2007;22:1748–1753.PubMed

11.

Scott AJ, Flowers O, Rowse G. A comparative study of the nature and magnitude of problems sleeping in inflammatory bowel disease (IBD) compared to healthy controls. Psychol Health Med. 2020;20:1–11.

12.

Chrobak AA, Nowakowski J, Zwolińska-Wcisło M, Cibor D, Przybylska-Feluś M, Ochyra K et al. Associations between chronotype, sleep disturbances and seasonality with fatigue and inflammatory bowel disease symptoms. Chronobiol Int. 2018;35:1142–1152.PubMed

13.

Becker J, Berger F, Schindlbeck KA, Poddubnyy D, Koch PM, Preiß JC et al. Restless legs syndrome is a relevant comorbidity in patients with inflammatory bowel disease. Int J Colorectal Dis. 2018;33:955–962.PubMed

14.

Cohen ER, Melmed GY. Making a case for patient-reported outcomes in clinical inflammatory bowel disease practice. Clin Gastroenterol Hepatol. 2018;16:603–607.PubMed

15.

Bewtra M, Brensinger CM, Tomov VT, Hoang TB, Sokach CE, Siegel CA et al. An optimized patient-reported ulcerative colitis disease activity measure derived from the Mayo score and the simple clinical colitis activity index. Inflam Bowel Dis. 2014;20:1070–1078.

16.

Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psych Res. 1989;28:193–213.

17.

Heslop P, Smith GD, Metcalfe C, Macleod J, Hart C. Sleep duration and mortality: the effect of short or long sleep duration on cardiovascular and all-cause mortality in working men and women. Sleep Med. 2002;3:305–314.PubMed

18.

Ayas NT, White DP, Manson JE, Stampfer MJ, Speizer FE, Malhotra A et al. A prospective study of sleep duration and coronary heart disease in women. Arch Int Med. 2003;163:205–209. https://doi.org/10.1001/archinte.163.2.205.CrossRef

19.

Spiegel K, Knutson K, Leproult R, Tasali E, Van Cauter E. Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. J Appl Physiol. 2005;99:2008–2019. https://doi.org/10.1152/japplphysiol.00660.2005.CrossRefPubMed

20.

Allen RP, Burchell BJ, MacDonald B, Hening WA, Earley CJ. Validation of the self-completed Cambridge-Hopkins questionnaire (CH-RLSq) for ascertainment of restless legs syndrome (RLS) in a population survey. Sleep Med. 2009;10:1097–1100.PubMed

21.

Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW et al. Restless legs syndrome/Willis–Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria–history, rationale, description, and significance. Sleep Med. 2014;15:860–873.PubMed

22.

Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001;2:297–307. https://doi.org/10.1016/S1389-9457(00)00065-4.CrossRefPubMed

23.

Morin CM, Belleville G, Bélanger L, Ivers H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011;34:601–608.PubMedPubMedCentral

24.

Horne JA, Östberg O. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol. 1976;25:958–968.

25.

Kantermann T, Sung H, Burgess HJ. Comparing the morningness-eveningness questionnaire and munich chronotype questionnaire to the dim light melatonin onset. J Biol Rhyt. 2015;30:449–453.

26.

Chakradeo PS, Keshavarzian A, Singh S, Dera AE, Esteban JPG, Lee AA et al. Chronotype, social jet lag, sleep debt and food timing in inflammatory bowel disease. Sleep Med. 2018;52:188–195.PubMedPubMedCentral

27.

Taillard J, Philip P, Chastang J-F, Bioulac B. Validation of Horne and Ostberg morningness-eveningness questionnaire in a middle-aged population of French workers. J Biol Rhyt. 2004;19:76–86.

28.

Paine S-J, Gander PH, Travier N. The epidemiology of morningness/eveningness: influence of age, gender, ethnicity, and socioeconomic factors in adults (30–49 years). J Biol Rhyt. 2006;21:68–76.

29.

Ong JC, Huang JS, Kuo TF, Manber R. Characteristics of insomniacs with self-reported morning and evening chronotypes. J Clin Sleep Med. 2007;3:289–294.PubMedPubMedCentral

30.

Chung F, Yegneswaran B, Liao P, Chung SA, Vairavanathan S, Islam S et al. Stop questionnairea tool to screen patients for obstructive sleep apnea. Anesthesiol J Am Soc Anesthesiol. 2008;108:812–821.

31.

Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979;6:65–70.

32.

Kim H-Y. Statistical notes for clinical researchers: assessing normal distribution (2) using skewness and kurtosis. Restor Dent Endod. 2013;38:52.PubMedPubMedCentral

33.

Sochal M, Małecka-Panas E, Gabryelska A, Talar-Wojnarowska R, Szmyd B, Krzywdzińska M et al. Determinants of sleep quality in inflammatory bowel diseases. J Clin Med. 2020;9:2921.PubMedCentral

34.

Singareddy R, Vgontzas AN, Fernandez-Mendoza J, Liao D, Calhoun S, Shaffer ML et al. Risk factors for incident chronic insomnia: a general population prospective study. Sleep Med. 2012;13:346–353.PubMedPubMedCentral

35.

Mai E, Buysse DJ. Insomnia: prevalence, impact, pathogenesis, differential diagnosis, and evaluation. Sleep Med Clin. 2008;3:167–174.PubMedPubMedCentral

36.

Scott AJ, Flowers O, Rowse G. Do specific types of sleep disturbances represent risk factors for poorer health‐related quality of life in inflammatory bowel disease? A longitudinal cohort study. Br J Health Psychol. 2020:e12457.

37.

Ballou S, Alhassan E, Hon E, Lembo C, Rangan V, Singh P et al. Sleep disturbances are commonly reported among patients presenting to a gastroenterology clinic. Dig Dis Sci. 2018;63:2983–2991. https://doi.org/10.1007/s10620-018-5237-7.CrossRefPubMed

38.

Taylor DJ, Mallory LJ, Lichstein KL, Durrence HH, Riedel BW, Bush AJ. Comorbidity of chronic insomnia with medical problems. Sleep. 2007;30:213–218.PubMed

39.

Burish MJ, Chen Z, Yoo SH. Emerging relevance of circadian rhythms in headaches and neuropathic pain. Acta Physiol. 2019;225:e13161.

40.

Hagenauer MH, Crodelle JA, Piltz SH, Toporikova N, Ferguson P, Booth V. The modulation of pain by circadian and sleep-dependent processes: a review of the experimental evidence. Women Math Biol. 2017; 1–21.

41.

Kivelä L, Papadopoulos MR, Antypa N. Chronotype and psychiatric disorders. Curr Sleep Med Rep. 2018;4:94–103.PubMedPubMedCentral

42.

Koo BB. Restless leg syndrome across the globe: epidemiology of the restless legs syndrome/Willis-Ekbom disease. Sleep Med Clin. 2015;10:189–205.PubMed

43.

Mosli MH, Bukhari LM, Khoja AA, Ashour NA, Aljahdali HR, Khoja OA et al. Inflammatory bowel disease and restless leg syndrome. Neurosci (Riyadh, S Arab). 2020;25:301–307.

44.

Strange C, Richard CL, Shan S, Phillips BA, Kanotra S, Drummond MB et al. A population-based estimate of the health care burden of obstructive sleep apnea using a STOP-BAG questionnaire in South Carolina. J Clin Sleep Med. 2020

45.

Vgontzas AN, Liao D, Pejovic S, Calhoun S, Karataraki M, Basta M et al. Insomnia with short sleep duration and mortality: the Penn State cohort. Sleep. 2010;33:1159–1164.PubMedPubMedCentral

46.

Vgontzas AN, Fernandez-Mendoza J, Liao D, Bixler EO. Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder. Sleep Med Rev. 2013;17:241–254.PubMedPubMedCentral

47.

Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016;165:125–133.PubMed

48.

Jacobs GD, Pace-Schott EF, Stickgold R, Otto MW. Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison. Arch Intern Med. 2004;164:1888–1896.PubMed

49.

Smith MT, Perlis ML, Park A, Smith MS, Pennington J, Giles DE et al. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psych. 2002;159:5–11.

50.

Morin CM. Cognitive behavioral therapy for chronic insomnia: state of the science versus current clinical practices. Ann Intern Med. 2015;163:236–237.PubMed

51.

Espie CA, Kyle SD, Williams C, Ong JC, Douglas NJ, Hames P et al. A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep. 2012;35:769–781.PubMedPubMedCentral

52.

Ritterband LM, Thorndike FP, Ingersoll KS, Lord HR, Gonder-Frederick L, Frederick C et al. Effect of a web-based cognitive behavior therapy for insomnia intervention with 1-year follow-up: a randomized clinical trial. JAMA Psych. 2017;74:68–75.

53.

Salwen-Deremer JK, Siegel CA, Smith MT. Cognitive behavioral therapy for Insomnia: a promising treatment for insomnia, pain, and depression in patients with IBD. Crohn’s Colitis 360. 2020;2:otaa052.

54.

Taylor DJ, Pruiksma KE. Cognitive and behavioural therapy for insomnia (CBT-I) in psychiatric populations: a systematic review. Int Rev Psych. 2014;26:205–213.

55.

Zeng L-N, Zong Q-Q, Yang Y, Zhang L, Xiang Y-F, Ng CH et al. Gender difference in the prevalence of Insomnia: a meta-analysis of observational studies. Front Psych. 2020;11.

56.

Johnson DA, Jackson CL, Williams NJ, Alcántara C. Are sleep patterns influenced by race/ethnicity–a marker of relative advantage or disadvantage? Evidence to date. Nat Sci Sleep. 2019;11:79.PubMed

57.

Williet N, Sandborn WJ, Peyrin-Biroulet L. Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease. Clin Gastroenterol Hepatol. 2014;12:1246–1256.PubMed

58.

Zeitz J, Ak M, Müller-Mottet S, Scharl S, Biedermann L, Fournier N et al. Pain in IBD patients: very frequent and frequently insufficiently taken into account. PLoS ONE. 2016;11:e0156666.PubMedPubMedCentral

59.

Edwards RR, Almeida DM, Klick B, Haythornthwaite JA, Smith MT. Duration of sleep contributes to next-day pain report in the general population. PAIN. 2008;137:202–207.PubMedPubMedCentral

60.

Finan PH, Goodin BR, Smith MT. The association of sleep and pain: an update and a path forward. J Pain. 2013;14:1539–1552.PubMedPubMedCentral

61.

Afolalu EF, Ramlee F, Tang NK. Effects of sleep changes on pain-related health outcomes in the general population: a systematic review of longitudinal studies with exploratory meta-analysis. Sleep Med Rev. 2018;39:82–97.PubMedPubMedCentral

62.

Taylor DJ, Wilkerson AK, Pruiksma KE, Williams JM, Ruggero CJ, Hale W et al. Reliability of the structured clinical interview for DSM-5 sleep disorders module. J Clin Sleep Med. 2018;14:459–464.PubMedPubMedCentral

Titel: Poor Sleep in Inflammatory Bowel Disease Is Reflective of Distinct Sleep Disorders
verfasst von: Jessica K. Salwen-Deremer
Michael T. Smith
Hannah G. Haskell
Colleen Schreyer
Corey A. Siegel
Publikationsdatum: 30.07.2021
Verlag: Springer US
Erschienen in: Digestive Diseases and Sciences / Ausgabe 7/2022
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI: https://doi.org/10.1007/s10620-021-07176-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypertonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Poor Sleep in Inflammatory Bowel Disease Is Reflective of Distinct Sleep Disorders

Abstract

Background

Aims

Methods

Results

Conclusions

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Metformin rückt in den Hintergrund

Update Innere Medizin

Springer Medizin

Abstract

Background

Aims

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2022

Visceral Adipose Tissue Inflammation and Radiographic Visceral-to-Subcutaneous Adipose Tissue Ratio in Patients with Cirrhosis

SNAT2/SLC38A2 Confers the Stemness of Gastric Cancer Cells via Regulating Glutamine Level

Regression and Random Forest Machine Learning Have Limited Performance in Predicting Bowel Preparation in Veteran Population

Utilization and Impact of Complementary and Alternative Medicines in Symptomatic Autoimmune Hepatitis Patients

Lactated Ringers Does Not Reduce SIRS in Acute Pancreatitis Compared to Normal Saline: An Updated Meta-Analysis

COVID-19 Vaccination in Patients with Inflammatory Bowel Disease: A Survey from China

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Metformin rückt in den Hintergrund

Update Innere Medizin